Cancer

Newer drugs are improving survival for men with metastatic prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men with prostate cancer that has spread outside the gland now have several newer drug options available for treatment, and research has found that taking any of them is likely to improve survival duration.

Revisiting options for improving results of breast reconstruction

Ted A. James, MD

Contributor

Women who choose breast reconstruction after mastectomy but are unhappy with the results have another option: fat grafting, in which liquefied tissue from another part of the body is injected into the reconstructed breast.

A more precise approach to fighting cancer

Matthew Solan

Executive Editor, Harvard Men's Health Watch

Precision medicine is an approach to fighting certain types of cancer that considers a person’s family history, environment, and health habits, along with genetic testing, to predict which medication will provide the most effective treatment.

Is there a link between alcohol and skin cancer?

An analysis of studies found an association between alcohol consumption and increased risk of certain skin cancers, but there is no solid evidence of a direct connection.

Study investigates treatment regret among prostate cancer survivors

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Surveys of over 900 men who were diagnosed with prostate cancer in the 1990s found that approximately 15% had some regret over their treatment choices. Study authors encourage doctors and patients to have frank and thorough discussions about about the risks and benefits of various forms of treatment for prostate cancer.

Time to rethink the debate on PSA testing

The debate about PSA screening for prostate cancer has been going on for decades, and research has been similarly divided. For most men, the best advice is to talk with your doctor so the benefits and risks of the test are clear.

Combination hormonal therapy boosts survival in men with aggressive prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

The results of two studies found that using the drug abiraterone in combination with other hormonal therapy drugs to treat aggressive prostate cancer produced more favorable results than the first-line therapy alone.

Yoga improves treatment-related symptoms in men with prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men who participated in yoga classes twice a week while being treated for prostate cancer reported less fatigue and better urinary and erectile function, compared to other men in the study who did not do yoga.

This just in: Exercise is good for you

Robert H. Shmerling, MD

Faculty Editor, Harvard Health Publishing

If you are trying to follow the recommended guidelines for physical activity, the best way to spend your time may be running, but a study of commuters found that those who walked or bicycled to work also had lower rates of heart disease and cancer.

Shopping for sunscreen: Are all brands equal?

The variety of sunscreens available can be confusing to consumers who want to know they are choosing a product that offers appropriate protection from harmful ultraviolet rays. New sunscreen ingredients currently in use in Europe are still in the pipeline waiting FDA approval in the US.